CD309, Human (Ramucirumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-CD309, Human (Ramucirumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD309, Human (Ramucirumab biosimilar)
CloneRamucirumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG1 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human CD309 Recombinant Antibody (Ramucirumab). Ramucirumab (LY3009806, IMC-1121B, trade name Cyramza) is a fully human monoclonal antibody (IgG1) developed for the treatment of solid tumors. This drug was developed by ImClone Systems Inc
Immunogenn/a
Other NamesAnti-CD309 Recombinant Antibody, Research Grade Ramucirumab, Anti-Human CD309 Recombinant Antibody(Ramucirumab), 1121B, IMC-1121B, LY3009806, Antibody Drug Analogues, Monoclonal Antibody, YR1195, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 15966-93-5
Catalog #YR1195
Priceplease inquire
Order / More InfoCD309, Human (Ramucirumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.